COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,740 Articles (22,502 medRxiv, 8,238 bioRxiv)

Most recent first Previous |  Page 1162: Articles 11611-11620  | Next

Counter-intuitive COVID-19 Trajectories - Explanations, Early Warning Indicator and Mitigation Strategies
Shayak, B., Sharma, M. M.
10.1101/2021.09.27.21264174 — Posted: 2021-09-29
Persistence of robust humoral immune response in COVID-19 convalescent individuals over 12 months after infection
Miyakawa, K., Kubo, S., Jeremiah, S. S., Go, H., Yamaoka, Y., Ohtake, N., Kato, H., Ikeda, S., Mihara, T., Matsuba, I., Sanno, N., Miyakawa, M., Shinkai, M., Miyazaki, T., Ogura, T., Ito, S., Kaneko, T., Yamamoto, K., Goto, A., Ryo, A.
10.1101/2021.09.27.21264013 — Posted: 2021-09-29
SARS-Cov-2 Infection versus Vaccine-Induced Immunity among Veterans
Young-Xu, Y., Smith, J., Korves, C.
10.1101/2021.09.27.21264194 — Posted: 2021-09-29 Discussion: Onsite
Mental Health Concerns Related to the COVID-19 Pandemic on Twitter in the UK
Zhang, D., Liu, Y., Zhang, S., Sun, L., Li, P., Anand, A., Xie, Z., Li, D.
10.1101/2021.09.27.21264177 — Posted: 2021-09-29
Monoclonal antibodies against SARS-CoV-2: potential game-changer still underused
Gentile, I., Maraolo, A. E., Buonomo, A. R., Nobile, M., Piscitelli, P., Miani, A., Schiano Moriello, N.
10.1101/2021.09.27.21264191 — Posted: 2021-09-29
The effects of communicating uncertainty around statistics on public trust: an international study
Kerr, J. R., van der Bles, A. M., Schneider, C., Dryhurst, S., Chopurian, V., Freeman, A. L., van der Linden, S.
10.1101/2021.09.27.21264202 — Posted: 2021-09-29
Prevalence of SARS-CoV-2: An age-stratified, population-based, seroepidemiological survey in Islamabad, Pakistan
Baig, M. A., Ansari, J. A., Ikram, A., Khan, M. A., Salman, M., Hussain, Z., Baig, M. Z. I., Chaudhry, A., Malik, M. W., Akram, K. S., Saeed, A., Ranjha, M. A., Sultan, F., Sabir, S.
10.1101/2021.09.27.21264003 — Posted: 2021-09-29 Discussion: Onsite
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents
Castro, V. M., Gunning, F. M., Perlis, R. H.
10.1101/2021.09.28.21264259 — Posted: 2021-09-29
How well does SARS-CoV-2 spread in hospitals?
Shirreff, G., Zahar, J.-R., Cauchemez, S., Temime, L., Opatowski, L.
10.1101/2021.09.28.21264066 — Posted: 2021-09-29
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
Acharya, C. B., Schrom, J., Mitchell, A. M., Coil, D. A., Marquez, C., Rojas, S., Wang, C. Y., Liu, J., Pilarowski, G., Solis, L., Georgian, E., Petersen, M., DeRisi, J., Michelmore, R., Havlir, D.
10.1101/2021.09.28.21264262 — Posted: 2021-09-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).